Resolutions to improve health typically include measures such as more exercise, a healthier diet and stopping smoking. But what about your gut microbiome? Taking steps to protect and improve it can ...
The response of the human gut pathogen Clostridioides difficile to clinically relevant antibiotics can be altered by antibiotic-induced reduction in the strength of gut microbiota inter-species ...
Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...
Vedanta Biosciences has “significantly reduced” its headcount to channel its remaining resources to its lead live bacteria ...
A total of 54% of adults in the United States were “not at all” familiar with clostridioides difficile (C. diff), a bacterial infection that causes nearly 30,000 deaths in the US each year, according ...
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...
Clostridioides difficile can form iron-storage organelles known as ferrosomes. These protect bacteria from iron toxicity and promote infection by acting as a countermeasure to the host’s defence ...
Researchers develop new method of encapsulating fecal bacteria to treat serious intestinal infection
Clostridioides difficile infection causes severe diarrhea and results in the death of nearly 20,000 patients in Europe each year. It is one of the most common hospital-acquired infections. When it ...
Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...
This year in review of 2025 milestones in Clostridioides difficile infection features coverage of research on infection patterns presented at the American Society for Microbiology Microbe 2025 meeting ...
Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results